文献速递血栓与止血

新生儿重症监护病房静脉与动脉血栓形成相关危险因素:多中心病例对照研究

Risk factors associated with venous and arterial neonatal thrombosis in the intensive care unit: a multicentre case-control study.
PubMed 文献 · Lancet Haematol · 2022-02-08

该研究基于美国31个IV级新生儿重症监护病房(NICU)的儿童医院新生儿数据库,开展病例对照研究,纳入1326例血栓病例和5304例对照。发现静脉血栓与血流感染、母亲糖尿病、腹部或胃肠道手术、血小板减少、延长机械通气及入院日龄≥7天独立相关;动脉血栓与母亲高血压、血小板减少、延长机械通气、入院日龄≥7天及小于胎龄独立相关。中心静脉装置(CAD)相关因素中,CAD持续时间≥21天及上下半身均置入CAD与血栓风险升高相关。

要点

  • 静脉血栓独立危险因素包括血流感染、母亲糖尿病、腹部或胃肠道手术、血小板减少、延长机械通气及入院日龄≥7天。
  • 动脉血栓独立危险因素包括母亲高血压、血小板减少、延长机械通气、入院日龄≥7天及小于胎龄。
  • CAD持续时间≥21天及上下半身均置入CAD与静脉和动脉血栓风险升高相关。

核心结论

  • 识别血栓相关危险因素有助于开发风险预测模型以预防血栓并改善结局。
  • 研究结果增进了对新生儿静脉与动脉血栓危险因素差异及CAD特征与新生儿血栓关联的理解。

研究设计与样本

  • 研究为在美国31个IV级NICU开展的病例对照研究,使用儿童医院新生儿数据库,时间为2010年1月1日至2016年12月13日。
  • 病例依据静脉或动脉血栓结局确定,对照按胎龄、中心静脉装置(CAD)存在与否、医院及入院年份匹配,按1:4随机选择。
  • 排除住院时间超过3天或心脏病患者后,纳入1326例血栓病例(1022例静脉血栓,362例动脉血栓,58例同时具有两种血栓并计入上述两组)和5304例随机选择的对照。

主要发现

  • 31个NICU共118 952例新入院,总体血栓发生率为每1000例NICU入院15.5例(95% CI 14.8-16.2)。
  • 静脉血栓独立相关因素:血流感染(OR 2.07,95% CI 1.72-2.49;p<0.0001)、母亲糖尿病(OR 1.62,95% CI 1.30-2.03;p<0.0001)、腹部或胃肠道手术(OR 1.36,95% CI 1.17-1.58;p<0.0001)、血小板减少(OR 2.44,95% CI 2.02-2.94;p<0.0001)、延长机械通气(OR 1.27,95% CI 1.10-1.46;p=0.0014)、入院日龄≥7天(OR 1.49,95% CI 1.28-1.74;p<0.0001)。
  • 动脉血栓独立相关因素:母亲高血压(OR 1.42,95% CI 1.05-1.91;p=0.030)、血小板减少(OR 2.20,95% CI 1.59-3.06;p<0.0001)、延长机械通气(OR 1.58,95% CI 1.24-2.01;p=0.0002)、入院日龄≥7天(OR 1.35,95% CI 1.05-1.74;p=0.0018)、小于胎龄(OR 1.56,95% CI 1.13-2.16;p=0.0003)。
  • CAD子集分析中,CAD持续时间≥21天与静脉血栓(OR 1.52,95% CI 1.15-2.01,p=0.0034)和动脉血栓(OR 1.98,95% CI 1.25-3.14,p=0.035)风险升高相关。
  • CAD子集分析中,上下半身均置入CAD与静脉血栓(OR 2.43,95% CI 1.92-3.08,p<0.0001)和动脉血栓(OR 1.58,95% CI 1.02-2.45,p=0.040)风险升高相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Critically ill infants are susceptible to thrombosis due to several risk factors. The aim of this study was to identify risk factors associated with venous and arterial thrombosis in neonates admitted to the neonatal intensive care unit (NICU) and to identify differences in risk factors for venous versus arterial thrombosis. METHODS: We conducted a case-control study at 31 level IV NICUs using the Children's Hospital Neonatal Database between Jan 1, 2010, and Dec 13, 2016, in the USA. Cases were identified on the basis of having an outcome of venous or arterial thrombosis. Controls were matched by gestational age, presence of a central access device (CAD), hospital, and admission year. Four controls per case (1:4) were randomly selected. Bivariable and multivariable regression analyses were performed to examine the associations between potential risk factors and venous or arterial thrombosis. CAD-related risk factors were analysed in the subset of neonates with a CAD. FINDINGS: We identified 118 952 new admissions to 31 NICUs. The overall thrombosis incidence was 15·5 per 1000 NICU admissions (95% CI 14·8-16·2). After exclusion of patients with a length of hospitalisation longer than 3 days or heart disease, the study included 1326 thrombosis cases (1022 with venous thrombosis and 362 with arterial thrombosis; 58 patients had both types of thrombosis and are included within both of these numbers) and 5304 randomly selected controls. Venous thrombosis was independently associated with bloodstream infection (odds ratio 2·07, 95% CI 1·72-2·49; p<0·0001), maternal diabetes (1·62, 1·30-2·03; p<0·0001), abdominal or gastrointestinal surgery (1·36, 1·17-1·58; p<0·0001), thrombocytopenia (2·44, 2·02-2·94; p<0·0001), prolonged mechanical ventilation (1·27, 1·10-1·46; p=0·0014), and age 7 days or older at admission (1·49, 1·28-1·74; p<0·0001). Arterial thrombosis was independently associated with maternal hypertension (1·42, 1·05-1·91; p=0·030), thrombocytopenia (2·20, 1·59-3·06; p<0·0001), prolonged mechanical ventilation (1·58, 1·24-2·01; p=0·0002), age 7 days or older at admission (1·35, 1·05-1·74; p=0·0018), and small for gestational age (1·56, 1·13-2·16; p=0·0003). In the CAD subset analysis, CAD duration of 21 days or longer (venous thrombosis: 1·52, 1·15-2·01, p=0·0034; arterial thrombosis: 1·98, 1·25-3·14, p=0·035) and CAD in both the upper and lower body (venous thrombosis: 2·43, 1·92-3·08, p<0·0001; arterial thrombosis: 1·58, 1·02-2·45, p=0·040) were associated with higher odds of thrombosis. INTERPRETATION: Identification of thrombosis-associated risk factors will be useful in developing a risk prediction model to prevent thrombosis and in improving outcomes. The study results add to the knowledge of the differences in risk factors for venous versus arterial thrombosis in neonates and to the understanding of the associations of CAD characteristics with neonatal thrombosis. FUNDING: Bristol-Myers Squibb-Pfizer Alliance.

来源:Lancet Haematol,查看原文。版权归原作者所有。

引用

  1. Bhat R, Kwon S, Zaniletti I, et al. Risk factors associated with venous and arterial neonatal thrombosis in the intensive care unit: a multicentre case-control study. Lancet Haematol. 2022. PMID: 35148820. doi:10.1016/S2352-3026(21)00399-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。